You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

List of Excipients in API trofinetide

✉ Email this page to a colleague

« Back to Dashboard

Excipients in NDA-approved (novel) drugs containing trofinetide

Subscribe to access the full database, or Subscribe
Company	Tradename	Ingredient	NDC	Excipient	Potential Generic Entry
Acadia Pharmaceuticals Inc	DAYBUE	trofinetide	63090-660	FD&C RED NO. 40	2030-03-10
Acadia Pharmaceuticals Inc	DAYBUE	trofinetide	63090-660	MALTITOL	2030-03-10
Acadia Pharmaceuticals Inc	DAYBUE	trofinetide	63090-660	METHYLPARABEN SODIUM	2030-03-10
>Company	>Tradename	>Ingredient	>NDC	>Excipient	>Potential Generic Entry

Detailed excipient profiles for trofinetide

Excipient focus: FD&C RED NO. 40

trofinetide drug variants containing FD&C RED NO. 40

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Acadia Pharmaceuticals Inc	trofinetide	63090-660
>Company	>Ingredient	>NDC

trofinetide drug variants not containing FD&C RED NO. 40

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: MALTITOL

trofinetide drug variants containing MALTITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Acadia Pharmaceuticals Inc	trofinetide	63090-660
>Company	>Ingredient	>NDC

trofinetide drug variants not containing MALTITOL

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: METHYLPARABEN SODIUM

trofinetide drug variants containing METHYLPARABEN SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Acadia Pharmaceuticals Inc	trofinetide	63090-660
>Company	>Ingredient	>NDC

trofinetide drug variants not containing METHYLPARABEN SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: PROPYLPARABEN SODIUM

trofinetide drug variants containing PROPYLPARABEN SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Acadia Pharmaceuticals Inc	trofinetide	63090-660
>Company	>Ingredient	>NDC

trofinetide drug variants not containing PROPYLPARABEN SODIUM

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: SUCRALOSE

trofinetide drug variants containing SUCRALOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Acadia Pharmaceuticals Inc	trofinetide	63090-660
>Company	>Ingredient	>NDC

trofinetide drug variants not containing SUCRALOSE

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Excipient focus: WATER

trofinetide drug variants containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
Acadia Pharmaceuticals Inc	trofinetide	63090-660
>Company	>Ingredient	>NDC

trofinetide drug variants not containing WATER

Subscribe to access the full database, or Subscribe
Company	Ingredient	NDC
>Company	>Ingredient	>NDC

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.